If you’ve seen Top Gun or the brand new Maverick film, then you definately’re most likely accustomed to the time period “missile lock.” It’s that candy spot when your goal is in your sights and completely aligned for a profitable hit. For our most cancers consultants, their goal, after all, is most cancers. And now, they’ve a brand new instrument that may make it simpler than ever to hit their mark: the MR-linac.
The MRI-guided radiation remedy system, MRIdian®, combines the superior visualization of magnetic resonance imaging (MRI) with a linear accelerator. This machine delivers high-dose radiation with a brand new depth of precision. “The combination of these two technologies really allows us to do amazing things that we couldn’t do before,” says radiation oncologist Einsley Janowski, MD, PhD. “It’s really a huge step forward.”
Only round 25 of those machines have been put in nationwide, and UVA Cancer Center is one in every of solely two facilities in Virginia so as to add this to their cancer-treating arsenal.
Why the MR-Linac Is a Gamechanger for Pancreatic Cancer Care
Radiation remedy has been used for over a century to deal with most cancers, and the expertise has continued to evolve to spice up treatment charges and restrict unwanted effects. The MR-linac is designed to beat a few of the limits of typical radiation remedy.
It creates extraordinarily detailed pictures, resulting in much less injury to regular tissue and thus, fewer unwanted effects.
The machine can also purpose at tumors in organs that transfer with respiratory and digestion, just like the pancreas, prostate, and rectum.
“In the past, radiation therapy was like aiming our gun at the target, then closing our eyes and pulling the trigger. Now, we’re going to be able to keep our eyes open as we pull the trigger and keep them open throughout the radiation treatment,” says Jeff Siebers, PhD.
Patients will even hold their eyes open — to assist the process by adjusting their respiratory. And the machine additionally permits for real-time therapy changes. Both of those components promise to enhance the accuracy and effectiveness of the remedy.
“It’s going to be another tool in our arsenal,” Janowski says. “It will allow us to be aggressive in treating some of those cancers like pancreatic cancer that are notoriously difficult to treat.”